AgeX Therapeutics, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 114.5 | -100% | -3.7 | -100% |
| P/S |
|
2.98 | 4.08 | -26.85% |
|
|
| P/BV |
|
0.079 | 9.4 | -99.16% |
|
|
| P/FCF |
|
0 | 46.57 | -100% |
|
|
| Ev/Ebitda |
|
-0.4521 | 17.79 | -102.54% |
|
|
| Ev/S |
|
31.29 | 4.42 | 607.45% |
|
|
| Ev/FCF |
|
-0.5697 | 54.59 | -101.04% |
|
|
| E/P |
|
0 | 0.2164 | -100% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-6921.83 | 19.84 | -34993.65% | -6668.72 | +3.8% |
| ROE |
|
-270.67 | -80.86 | 234.75% |
|
|
| ROA |
|
-123.72 | 6.71 | -1944.2% |
|
|
| ROIC |
|
0 | 15.68 | -100% |
|
|
| ROS |
|
-10424.65 | 10.27 | -101613% |
|
|
| ROCE |
|
-185.89 | 18.01 | -1131.93% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.4441 | 2.91 | -115.24% | -1.15 | -61.42% |
| Nеt Debt/Ebitda |
|
-0.409 | 3.74 | -110.95% |
|
|
| Debt/Ratio |
|
0.3648 | 0.2654 | 37.44% |
|
|
| Debt/Equity |
|
0 | 4.49 | -100% |
|
|
| Debt/Net Income |
|
-0.2949 | 6.5 | -104.54% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 1.32 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 6.4 | -100% | ||
| DSI |
|
0 | 0.7399 | -100% |
|
|
| Average dividend growth |
|
0 | -2.86 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 1.3 | -100% |
|
|
| Average percentage for payments |
|
0 | 77.74 | -100% |
|
|
| Difference from average difference in sector |
|
-1.32 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
-91.65 | 260.11 | -135.24% | ||
| Growth impulse Ebitda in 5 years |
|
-15.27 | 275.1 | -105.55% | ||
| Growth impulse Net Income in 5 years |
|
19.38 | 353.29 | -94.51% | ||
| Growth impulse FCF in 5 years |
|
-27.78 | 232.6 | -111.94% | ||
| Growth impulse EPS in 5 years |
|
4028.55 | 354.79 | 1035.47% |
IP Score
3.55/10
